AIMS Institute

1136 Poplar Pl S
Seattle, WA 98144

Phone: (206) 420-1321
Fax: (833) 584-0067

Send Us A Message
  • This field is for validation purposes and should be left unchanged.
  • Please use this form for general information purposes only. DO NOT send personal health information through this form. Specific patient care must be addressed during your appointment.
Business Hours

Monday – Friday: 9:00 am – 6:00 pm
Saturday: By Appointment Only

Our Location

Latest Blog Posts

What the Cancer Community Actually Needs from Psychedelic Care

What the Cancer Community Actually Needs from Psychedelic Care

By Anne Hamilton, JD, MA When people talk about psychedelic therapy, the focus usually stays on depression, trauma, or neuroplasticity. These conversations matter, but they rarely touch the existential fear that defines the lives of people facing life-threatening illness. I write this not only as an attorney and psychedelic nonprofit executive director, but as someone who has lived this terrain myself as a cancer survivor. I was raised Catholic and grew up with a respect for ritual and mystery, even when filtered through institutions. My early life followed a logical sequence. I studied at Notre Dame, earned a master’s degree ...

Read More
Stellate Ganglion Block Effectiveness for PTSD, Anxiety, and Depression in Psychiatric Outpatients: A Retrospective Analysis

Stellate Ganglion Block Effectiveness for PTSD, Anxiety, and Depression in Psychiatric Outpatients: A Retrospective Analysis

https://scholarworks.seattleu.edu/dnp-projects/166/ The prevalences of Post-Traumatic Stress Disorder (PTSD), generalized anxiety disorder (GAD), and major depressive disorder (MDD) have risen significantly in recent years, particularly following the COVID-19 pandemic. Many individuals remain symptomatic despite conventional treatments, highlighting the need for novel, integrative interventions. Stellate Ganglion Block (SGB), a procedure targeting the cervical sympathetic chain to modulate the autonomic nervous system, has emerged as a promising therapy for treatment-resistant psychiatric symptoms. Evaluating data from the PTSD Checklist for DSM-5 (PCL-5), Generalized Anxiety Disorder-7 (GAD-7), and Patient Health Questionnaire-9 (PHQ-9), this retrospective study examined the clinical outcomes of PTSD, anxiety, and depression symptoms ...

Read More

Accessibility Tools

Increase TextIncrease Text
Decrease TextDecrease Text
GrayscaleGrayscale
Invert Colors
Readable FontReadable Font
Reset
Call Us Text Us